activity which is similar to thiourea derivative 4 whilst the
transport properties of all the compounds are enhanced in the
presence of valinomycin-K+. These initial studies with simple
systems suggest that these hydrogen-bonding motifs may be
optimised for anion complexation and transport. We are
currently working to incorporate these new anion transport
hydrogen bonding motifs into more efficient transporters for
chloride and other anions.
We thank the EPSRC for funding and for use of the
crystallographic facilities at the University of Southampton.
Notes and references
z Crystal data for 1: C14H20N4,
M = 244.34, orthorhombic,
a = 10.2071(2) A, b = 11.2105(3) A, c = 24.2602(6) A, V =
2776.01(11) A3, T = 120 K, P212121 (no. 19), Z = 8, 27 023 reflections
measured, 3585 unique (Rint = 0.0775) of which 3585 were used in the
calculations, R1 = 0.0546 (2806 with F 4 2s(F)), for this light atom
structure Friedel opposites were merged and delta f’’ value for all
elements set to zero.
Fig. 4 Chloride efflux promoted by 0.02 molar equiv. of receptors
1–4 in the presence and absence of valinomycin (0.02 molar equiv.)
from unilamellar POPC vesicles loaded with 489 mM KCl buffered to
pH 7.2 with sodium phosphate salts. The vesicles were dispersed in
489 mM KNO3 buffered to pH 7.2 with 5 mM sodium phosphate salts.
At the end of the experiment, detergent was added to lyse the vesicles
and calibrate the ISE to 100% chloride release. Each point represents
the average of three trials.
2: Cystal data for C14H15N4F5,
M = 334.30, monoclinic,
a = 13.6862(9) A, b = 10.6669(7) A, c = 11.3955(7) A, b =
109.57(4), V = 1567.52(17) A3, T = 120 K, P21/c (no. 14), Z = 4,
25 328 reflections measured, 3614 unique (Rint = 0.0916) of which
3614 were used in the calculations, R1 = 0.0706 (2773 with
F 4 2s(F)), carbon 12 and 13 of the alkyl chain in 2 are disordered
over 2 positions with an occupancy of 0.5 each.
1 P. A. Gale, Acc. Chem. Res., 2011, 44, 216–226; C. J. E. Haynes
and P. A. Gale, Chem. Commun., 2011, DOI: 10.1039/c1cc12061a;
A. P. Davis, D. N. Sheppard and B. D. Smith, Chem. Soc. Rev.,
2007, 36, 348–357; J. T. Davis, O. Okunola and R. Quesada, Chem.
Soc. Rev., 2010, 39, 3843–3862.
2 J. T. Davis, P. A. Gale, O. A. Okunola, P. Prados, J. C. Iglesias-
Sanchez, T. Torroba and R. Quesada, Nat. Chem., 2009, 1,
138–144; P. A. Gale, C. C. Tong, C. J. E. Haynes, O. Adeosun,
D. E. Gross, E. Karnas, E. M. Sedenberg, R. Quesada and
J. L. Sessler, J. Am. Chem. Soc., 2010, 132, 3240–3241.
3 N. Busschaert, P. A. Gale, C. J. E. Haynes, M. E. Light,
S. J. Moore, C. C. Tong, J. T. Davis and W. A. Harrell Jr., Chem.
Commun., 2010, 46, 6252–6254.
4 N. J. Andrews, C. J. E. Haynes, M. E. Light, S. J. Moore,
C. C. Tong, J. T. Davis, W. A. Harrell Jr. and P. A. Gale, Chem.
Sci., 2011, 2, 256–260.
5 P. B. Smith and C. Crespi, Biochem. Pharmacol., 2002, 63,
1941–1948; R. C. A. Onderwater, J. N. M. Commandeur,
E. J. Groot, A. Sitters, W. M. P. B. Menge and N. P. E.
Vermeulen, Toxicology, 1998, 125, 117–129.
6 S. A. Svarovsky, R. H. Simoyi and S. V. Makarov, J. Phys. Chem. B,
2001, 105, 12634–12643.
7 G. J. Durant, J. C. Emmett, C. R. Ganellin, P. D. Miles,
M. E. Parsons, H. D. Prain and G. R. White, J. Med. Chem.,
1977, 20, 901–906.
8 C. G. McCarty, R. V. Chastain and D. M. Wieland, J. Chem. Soc. D,
1971, 198–199.
9 S. Boverie, M.-H. Antoine, F. Somers, B. Becker, S. Sebille,
R. Ouedraogo, S. Counerotte, B. Pirotte, P. Lebrun and P. de
Tullio, J. Med. Chem., 2005, 48, 3492–3503.
in chloride transport when both valinomycin and one of the
receptors 1–4 is present. For example a total chloride efflux of
58% was observed for 2 and valinomycin present together
compared to 29% and 5% in the presence of either receptor
alone in the previous experiment. A similar result was obtained
with compound 4, namely an enhancement from 30% in
absence of valinomycin to 56% in the present of both, 4 and
valinomycin. The chloride transport for 1 and 3 is increased
from 5% to 23% if valinomycin is added in an equimolar
amount. The chloride efflux for the receptors 1–4 at 270 s in
the absence and presence of valinomycin are given in Table 2.
As no potassium gradient is present, the enhancement observed
may be caused by the presence of valinomycin bound potassium
cations in the membrane possibly either enhancing extraction
of the anions from the aqueous phase into the membrane or
stabilizing the receptor bound anion complexes in the lipid
bilayer.
This work has demonstrated that thiourea isosteres such as
functionalised cyanoguanidines and the hexyl derivative of
3-amino-1,2,4-benzothiadiazine-1,1-dioxide are capable of
binding and transporting anions. Compound 2 shows transport
10 P. Lebrun, B. Becker, N. Morel, P. Ghisdal, M.-H. Antoine, P. de
Tullio and B. Pirotte, Biochem. Pharmacol., 2008, 75, 468–475;
P. de Tullio, L. Dupont, P. Francotte, S. Counerotte, P. Lebrun and
B. Pirotte, J. Med. Chem., 2006, 49, 6779–6788; B. Pirotte, P. de Tullio,
Q.-A. Nguyen, F. Somers, P. Fraikin, X. Florence, P. Wahl,
J. B. Hansen and P. Lebrun, J. Med. Chem., 2010, 53, 147–154.
11 P. de Tullio, S. Boverie, B. Becker, M.-H. Antoine, Q.-A. Nguyen,
P. Francotte, S. Counerotte, S. Sebille, B. Pirotte and P. Lebrun,
J. Med. Chem., 2005, 48, 4990–5000.
Table 2 Chloride efflux (%) promoted by 0.02 molar equiv. of
receptors 1–4 in the absence and presence of valinomycin (0.02 molar
equiv.) from unilamellar POPC vesicles loaded with 489 mM KCl
buffered to pH 7.2 with sodium phosphate salts after 270 s. The
vesicles were dispersed in 489mM KNO3 buffered to pH 7.2 with
5 mM sodium phosphate salts
Chloride efflux at 270 s (%)
12 L. Novak, M. Hanania, P. Kovacs, C. E. Kovacs, P. Kolonits and
C. Szantay, Synth. Commun., 1999, 29, 1757–1766; P. de Tullio,
B. Pirotte, F. Somers, S. Boverie, F. Lacan and J. Delarge,
Tetrahedron, 1998, 54, 4935–4942.
1
2
3
4
Absence of valinomycin
Presence of valinomycin
5
23
29
58
5
23
30
56
13 M. J. Hynes, J. Chem. Soc., Dalton Trans., 1993, 311–312.
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 7641–7643 7643